Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Investigating the Biochemical Impacts of Hemodynamics in Bicuspid Aortic Valve Associated Ascending Aortic Dilatation Development
FY 2024-25
Summary
Bicuspid aortic valves (BAVs) are the most prevalent congenital heart defect in adults, affecting around 2% of the global population and causing more fatalities and complications than all other congenital heart abnormalities combined. Patients with BAVs are more prone to have ascending aortic dilatation (AAD) which increases their risk of dissection or rupture of their aorta. It is still uncertain whether BAV-associated aortopathy is caused by genetic factors or aberrant blood flow (hemodynamics), although both are likely involved. My project aims to isolate and investigate the effects of hemodynamics on the development of AAD associated with BAVs. To do so, I will use a novel BAV-AAD mouse model established in our lab. In this model, a small portion of mice with mutated natriuretic peptide receptor 2 are born with BAVs whereas the rest are born with normal tricuspid aortic valves (TAVs). Despite the same genetic background, aortas in BAV mice dilatate more than the TAV mice, suggesting the differences are due to disturbed hemodynamics associated with the BAV. I hypothesize that aberrant hemodynamics cause perturbations in the normal aorta transcriptome to contribute to disease development. I will test this hypothesis using echo-particle imaging velocimetry to identify flow impingement zones, and correlating this imaging information to biochemical information obtained from spatial transcriptomics done using VisiumHD. Additional validation experiments, using sc-RNA seq and immunostaining, will be done on mouse aortic tissue and human tissue to confirm any novel transcripts and signalling pathways involved in flow-regulated AAD development. Ultimately, I expect these studies will identify biomarkers for disease risk stratification and new therapeutic targets for improved medical management of the millions of at-risk BAV patients.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518357
Name
Guruji Vrushali
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - B
Projecttitle
Investigating the Biochemical Impacts of Hemodynamics in Bicuspid Aortic Valve Associated Ascending Aortic Dilatation Development
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Aneurysm; Ascending Aortic Dilation; Bicuspid Aortic Valve; C-Type Natriuretic Peptide; Congenital Heart Defects; Echocardiography; Genomics; Hemodynamics; Spatial Transcriptomics; Wall Shear Stress
Abstract
Bicuspid aortic valves (BAVs) are the most prevalent congenital heart defect in adults, affecting around 2% of the global population and causing more fatalities and complications than all other congenital heart abnormalities combined. Patients with BAVs are more prone to have ascending aortic dilatation (AAD) which increases their risk of dissection or rupture of their aorta. It is still uncertain whether BAV-associated aortopathy is caused by genetic factors or aberrant blood flow (hemodynamics), although both are likely involved. My project aims to isolate and investigate the effects of hemodynamics on the development of AAD associated with BAVs. To do so, I will use a novel BAV-AAD mouse model established in our lab. In this model, a small portion of mice with mutated natriuretic peptide receptor 2 are born with BAVs whereas the rest are born with normal tricuspid aortic valves (TAVs). Despite the same genetic background, aortas in BAV mice dilatate more than the TAV mice, suggesting the differences are due to disturbed hemodynamics associated with the BAV. I hypothesize that aberrant hemodynamics cause perturbations in the normal aorta transcriptome to contribute to disease development. I will test this hypothesis using echo-particle imaging velocimetry to identify flow impingement zones, and correlating this imaging information to biochemical information obtained from spatial transcriptomics done using VisiumHD. Additional validation experiments, using sc-RNA seq and immunostaining, will be done on mouse aortic tissue and human tissue to confirm any novel transcripts and signalling pathways involved in flow-regulated AAD development. Ultimately, I expect these studies will identify biomarkers for disease risk stratification and new therapeutic targets for improved medical management of the millions of at-risk BAV patients.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Guruji, Vrushali
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~